Volume 131, Issue 37 pp. 13122-13127
Zuschrift

Efficient Innate Immune Killing of Cancer Cells Triggered by Cell-Surface Anchoring of Multivalent Antibody-Recruiting Polymers

Annemiek Uvyn

Annemiek Uvyn

Department of Pharmaceutics, Ghent University, Belgium

These authors contributed equally to this work.

Search for more papers by this author
Dr. Ruben De Coen

Dr. Ruben De Coen

Department of Pharmaceutics, Ghent University, Belgium

These authors contributed equally to this work.

Search for more papers by this author
Mandy Gruijs

Mandy Gruijs

Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Amsterdam, The Netherlands

Search for more papers by this author
Cees W. Tuk

Cees W. Tuk

Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Amsterdam, The Netherlands

Search for more papers by this author
Jana De Vrieze

Jana De Vrieze

Department of Pharmaceutics, Ghent University, Belgium

Search for more papers by this author
Prof. Dr. Marjolein van Egmond

Prof. Dr. Marjolein van Egmond

Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Amsterdam, The Netherlands

Search for more papers by this author
Prof. Dr. Bruno G. De Geest

Corresponding Author

Prof. Dr. Bruno G. De Geest

Department of Pharmaceutics, Ghent University, Belgium

Search for more papers by this author
First published: 17 June 2019
Citations: 10

Abstract

Binding of monoclonal antibodies (mAbs) onto a cell surface triggers antibody-mediated effector killing by innate immune cells through complement activation. As an alternative to mAbs, synthetic systems that can recruit endogenous antibodies from the blood stream to a cancer cell surface could be of great relevance. Herein, we explore antibody-recruiting polymers (ARPs) as a novel class of immunotherapy. ARPs consist of a cell-binding motif linked to a polymer that contains multiple small molecule antibody-binding motifs along its backbone. As a proof of concept, we employ a lipid anchor that inserts into the phospholipid cell membrane and make use of a polymeric activated ester scaffold onto which we substitute dinitrophenol as an antibody-binding motif. We demonstrate that ARPs allow for high avidity antibody binding and drive antibody recruitment to treated cells for several days. Furthermore, we show that ARP-treated cancer cells are prone to antibody-mediated killing through phagocytosis by macrophages.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.